NES-ZIONA, ISRAEL / ACCESSWIRE / February 21, 2024 / Mike Williams made a name for himself making difficult endzone catches...
Topline growth with better quality revenue mixIncrease in subscription revenue (fixed) vs usage based revenue (variable), reducing seasonality impact with...
Cost containment and care management company extends category leadership with new products and record savings for clients and their members.CHICAGO,...
~ Raises Approximately $2.6 Million in Gross Proceeds ~~ Retires $1.25 Million in Secured Debt ~LOS GATOS, CA / ACCESSWIRE...
MIAMI, FL / ACCESSWIRE / February 21, 2024 / AllStar Health Brands Inc (OTC PINK:ALST) ("AllStar" or "the Company") announces...
CHARLOTTE, NC / ACCESSWIRE / February 21, 2024 / QC Kinetix, a leader in the field of regenerative medicine, proudly...
FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the “Company”) (NASDAQ: MOTS), a medical technology...
Targeted company, based in Colombia, holds a unique cannabis genetics licenseAUSTIN, Texas, Feb. 21, 2024 (GLOBE NEWSWIRE) -- via IBN...
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI),...
UDENYCA ONBODY™ UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqvFull Prescribing Information, including instructions for use, is...
Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record...
HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical...
Partnership Brings Pioneering Approach to Incorporating Advanced Colorectal Cancer Detection Into Country’s Healthcare SystemBERKELEY, Calif. and MAINZ, Germany, Feb. 21,...
CAMBRIDGE, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering...
Randomized controlled trial designed to evaluate the safety and effectiveness of the Route 92 Medical 0.088” HiPoint Reperfusion Catheter, part...
Attn: Assignment EditorTORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- As the Ford government counters horror stories about unprecedented emergency department...
BURLINGTON, Mass. and JERUSALEM, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
BRIDGEWATER, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical...
Topline Results Expected in Q2 2024This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics...
Vancouver, British Columbia--(Newsfile Corp. - February 21, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or...